Novolog’s 60% Acquisition of Gsap

Firon advised Gsap on the transaction.

Gsap, an international consulting firm for healthcare companies, executed a sale of 60% to Novolog, in consideration for NIS 33 million (plus NIS 12 million).

NovoLog is a rapid-acting insulin that helps lower mealtime blood sugar spikes in adults and children with diabetes.

The Firon team was led by Advs. Udi Efron (Picture), Sarit Moussayoff and Eden Salomon Lyabock.

Involved fees earner: Eden Salomon Lyabock – Firon Bar-Nir; Sarit Moussayoff – Firon Bar-Nir; Udi Efron – M. Firon & Co.;

Law Firms: Firon Bar-Nir; M. Firon & Co.;

Clients: Gsap;